Internal balance sheet | 31.12.2020 | 31.12.2019 |
ASSETS | ||
NON-CURRENT ASSETS | ||
Intangible assets Other long term expenses Intangible assets in total |
3 841 820,63 689 283,18 4 531 103,81 |
|
Tangible assets Other long term expenses Tangible assets in total |
136 293,60 2 251 678,17 144 196,10 2 532 167,87 |
235 593,19 2 093 295,81 118 039,51 2 446 928,51 |
Investments Other shares and similar rights of ownership |
1 558,60 |
1 726,79 |
CURRENT ASSETS |
||
Inventories Materials and accessories Inventories in total |
3 321 792,00 429 543,18 3 751 335,18 |
4 206 277,00 399 496,00 4 605 773,00 |
Receivables Accounts receivable Receivables in total |
4 995 762,99 |
|
Financial instruments Other shares and stock |
47 985 815,02 |
45 680 957,38 |
Cash in hand and in bank |
33 576 540,62 |
32 940 118,61 |
TOTAL ASSETS | 98 586 808,45 | 94 620 397,43 |
EQUITY AND LIABILITIES | ||
EQUITY | ||
Blood Service Research Fund Profit for previous financial years Profit for the financial year TOTAL EQUITY |
23 546 309,70 62 812 506,45 2 128 216,02 88 487 032,17 |
23 546 309,70 53 339 493,22 9 473 013,23 86 358 816,15 |
EXTERNAL LIABILITIES |
||
Current Accounts payable Current liabilities in total
|
|
|
TOTAL EQUITY AND LIABILITIES |
98 586 808,45 |
94 620 397,43 |